Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mitragynine ELISA Detects Designer Drug

By LabMedica International staff writers
Posted on 17 Apr 2013
A designer drug originates from Mitragyna speciosa, an uncontrolled plant found in South East Asia. More...


Called Kratom, the drug has become more popular because it is easily available on the internet and in head shops [shops specializing in paraphernalia used with or related to illegal drugs]. It is marketed as a means to combat fatigue, pain, and depression. A new immunoassay for Kratom was developed by Randox Toxicology (Crumlin, United Kingdom) and provides a rapid solution for the detection of Mitragynine and its metabolites.

From exotic plants to synthetic blends, designer drugs are problematic for forensic toxicologists as waves of new compounds with differing chemical properties quickly flood the market. Immunoassays provide a straightforward method for laboratory drug screening, allowing a large number of specimens to be screened relatively quickly. A novel ELISA developed by Randox Toxicology can detect Mitragynine and its metabolites; 9-O-Desmethylmitragynine, 7-alpha-Hydroxymitragynine and 7-alpha-Acetoxymitragynin in urine and blood specimens, providing valuable information for further analysis.

The Randox Toxicology enzyme-linked immunosorbent assay (ELISA) can detect Mitragynine and its metabolites; 9-O-Desmethylmitragynine, 7-alpha-Hydroxymitragynine, and 7-alpha-Acetoxymitragynin in urine and blood specimens, providing important information for further analysis.

As with other designer drugs such as “Spice” and “Bath Salts,” Kratom is marketed as a “legal high,” which can mislead users to believe that the drug is safe to use. Several cases of psychosis resulting from the use of Kratom have been reported, with individuals addicted to the drug exhibiting psychotic symptoms such as hallucinations, delusion, and confusion. Mitragynine and several related alkaloids naturally occur in the Mitragyna speciosa plant, creating psychoactive properties.

Randox Toxicology, through its research and development capabilities, is able to quickly develop reliable assays for designer drugs. The company has developed a range of rapid immunoassays on ELISA and Biochip arrays, including Synthetic Cannabinoids and Synthetic Cathinones, commonly referred to as “Bath Salts.”

Related Links:
Randox Toxicology


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.